News

Labetalol HCl Injection is the generic equivalent of Prometheus Laboratories’ Trandate (Labetalol HCl) Injection. Labetalol HCl Injection is an adrenergic receptor blocking agent that has both selective alpha1-adrenergic

Millipore’s current research with BDI is focused on developing new technology platforms for in-process testing and real-time monitoring in biopharmaceutical manufacturing. Dennis Harris, chief scientific officer at Millipore,

The license agreement covers intellectual property rights for AMD-related genetic variants that have been confirmed in multiple clinical studies around the world. The portfolio of intellectual property being

The license agreement covers extensive intellectual property rights for AMD-related genetic variants that have been confirmed in multiple clinical studies around the world. The portfolio of intellectual property

Kevin Hrusovsky, president and CEO of Caliper Life Sciences, said: “We have partnered with key thought leaders and customers to create the Sciclone G3 platform, which expands Caliper’s

The official opening ceremony was performed by Friedrich Conzen, major of Dusseldorf. Dr Simon Moroney, chief executive officer of MorphoSys Group, also attended along with Dieter Feger, Head

Reportedly, iCyt plans to develop advanced technologies and deliver new products in collaboration with Sony. Gary Durack will continue to lead the company through this period of growth

The company said that these high-temperature polymers can be used in applications such as respiratory devices, fluid collection containers and others that require optimum strength, chemical resistance and

The agreement to purchase Topigen was announced to the market on 12 January, 2010. An additional 5.0 million shares will be issued subject to the achievement of certain